Apyx Medical Corporation (APYX) Dividend History

Apyx Medical Corporation (APYX) develops and markets medical devices, primarily focusing on advanced tissue and nerve ablation techniques. The company's flagship product, Renuvion/JPlasma, uses cold plasma technology for cosmetic skin tightening, body contouring, and minimally invasive surgical procedures, promoting tissue coagulation and rejuvenation. Apyx aims to enhance aesthetic and surgical outcomes through innovative energy-based platforms.

5115 Ulmerton Road, Clearwater, FL, 33760
Phone: (727) 384-2323
Website: https://apyxmedical.com

Dividend History

Apyx Medical Corporation currently does not pay dividends

Company News

Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™

Apyx Medical Corporation received FDA clearance for its AYON Body Contouring System, which combines multiple technologies for body contouring procedures. The company plans to launch the system with key surgeons in the second half of 2025.

GlobeNewswire Inc.
Butterfly Network's Stock Surges on iQ3 Device Launch in Europe

Butterfly Network's stock surged 26.9% after the company announced the commercial launch of its third-generation handheld point-of-care ultrasound system, Butterfly iQ3, in Europe. The device's strong uptake in the U.S. market and its advanced features are driving investor optimism.

Benzinga

Featured Companies: BFLY BSX UHS
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Apyx (APYX) delivered earnings and revenue surprises of -22.22% and 6.27%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research

Featured Companies: MDT

Page data last updated 07/23/2025 14:43:00 UTC